Practical approach for using Medicare data to estimate costs for cost–effectiveness analysis-Reference-Cited by-同舟云学术

Practical approach for using Medicare data to estimate costs for cost–effectiveness analysis

Published:2005-04 Issue:2 Volume:5 Page:153-162
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Tumeh John W,Moore Susan G,Shapiro Rachel,Flowers Christopher R

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737167.5.2.153

Reference14 articles.

1. Luce B. Estimating costs in cost-effectiveness analysis. In:Cost-Effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB (Eds). Oxford University Press, NY, USA, 176–213 (1996).

2. Emerging standardization in pharmacoeconomics

3. Economic foundations of cost-effectiveness analysis

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysis;Translational Lung Cancer Research;2024-04

2. First-line versus second-line use of pralsetinib in treatment of rearranged during transfection (RET) fusion-positive advanced non-small cell lung cancer: a cost-effectiveness analysis;Translational Lung Cancer Research;2023-09

3. Cost-Effectiveness of Forgoing Postoperative Catheter Angiography After Microsurgical Occlusion of Spinal Dorsal Intradural Arteriovenous Fistulas;World Neurosurgery;2023-08

4. Early Total Hip Arthroplasty is a Cost-Effective Treatment for Severe Radiographic Slipped Capital Femoral Epiphysis Over an Individual's Lifetime;The Journal of Arthroplasty;2023-05

5. Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors;JAMA Network Open;2023-02-23